These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation]. Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408 [TBL] [Abstract][Full Text] [Related]
23. Haemopoietic stem cell transplantation in autoimmune diseases: a European perspective. Hough RE; Snowden JA; Wulffraat NM Br J Haematol; 2005 Feb; 128(4):432-59. PubMed ID: 15686452 [TBL] [Abstract][Full Text] [Related]
24. [Effects of allogeneic hematopoietic stem cell transplantation with very-high-dose conditioning regimen for refractory leukemia]. Liu QF; Sun J; Xu D; Zhang Y; Fan ZP; Wei YQ; Meng FY; Zhou SY Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1117-9. PubMed ID: 15485779 [TBL] [Abstract][Full Text] [Related]
26. Allogeneic transplantation for the elderly patient with acute myelogenous leukemia or myelodysplastic syndrome. de Lima M; Giralt S Semin Hematol; 2006 Apr; 43(2):107-17. PubMed ID: 16616044 [TBL] [Abstract][Full Text] [Related]
27. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation. Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449 [TBL] [Abstract][Full Text] [Related]
29. Clinically demonstrable anti-autoimmunity mediated by allogeneic immune cells favorably affects outcome after stem cell transplantation in human autoimmune diseases. Hinterberger W; Hinterberger-Fischer M; Marmont A Bone Marrow Transplant; 2002 Dec; 30(11):753-9. PubMed ID: 12439698 [TBL] [Abstract][Full Text] [Related]
30. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients. Sanz J; Arriaga F; Montesinos P; Ortí G; Lorenzo I; Cantero S; Puig N; Moscardó F; de la Rubia J; Sanz G; Sanz MA Bone Marrow Transplant; 2007 May; 39(9):555-61. PubMed ID: 17351645 [TBL] [Abstract][Full Text] [Related]
31. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor. Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917 [TBL] [Abstract][Full Text] [Related]
32. Outcome and long-term follow-up of alloreactive donor lymphocyte infusions given for relapse after myeloablative allogeneic hematopoietic stem cell transplantations (HSCT). Michallet AS; Nicolini F; Fürst S; Le QH; Dubois V; Hayette S; Bourgeot JP; Tremisi JP; Thomas X; Gebuhrer L; Michallet M Bone Marrow Transplant; 2005 Mar; 35(6):601-8. PubMed ID: 15756285 [TBL] [Abstract][Full Text] [Related]
33. [Allogeneic hematopoietic stem cell transplantation for 16 patients with aplastic anemia]. Zhai WH; Wang M; Zhou Z; Zhai WJ; Zhang RL; Wang H; Song AX; Feng SZ; Han MZ Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):78-82. PubMed ID: 17650665 [TBL] [Abstract][Full Text] [Related]